Antibody-mediated oral delivery of therapeutic DNA for type 2 diabetes mellitus
Abstract Background Diabetes mellitus (DM) is a chronic progressive metabolic disease that involves uncontrolled elevation of blood glucose levels. Among various therapeutic approaches, GLP-1 prevents type 2 diabetes mellitus (T2DM) patients from experiencing hyperglycemic episodes. However, the sho...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | Biomaterials Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40824-018-0129-7 |